Pregabalin + Methylcobalamin + Duloxetine Capsule Franchise in Ahmedabad

Neuropathic Pain Capsule Supplier in Mumbai

Neuro Medicine Distributor in Delhi

Neurology Pharma Franchise in Bangalore

Pregabalin Methylcobalamin Capsule Stockist in Hyderabad
Neuropathic Pain Capsule Manufacturer & Exporter in Chandigarh

Home/Products /pregabalin-75mg-methylcobalamin-1500mcg-duloxetine-30mg-capsule

Pregahike Trio 30 Capsule

Composition : Pregabalin (75mg) + Methylcobalamin (1500mcg) + Duloxetine (30mg) Capsule

Dosage Form : Capsule

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Pregahike DM 75/30 Capsule contains Pregabalin 75mg + Methylcobalamin 1500mcg + Duloxetine 30mg, a triple-action therapy for effective management of neuropathic pain, nerve damage, and chronic pain conditions. Pregabalin reduces abnormal nerve signals, Methylcobalamin promotes nerve regeneration and repair, and Duloxetine enhances central pain modulation, ensuring complete nerve support.

This combination provides superior therapeutic benefits and is highly trusted by prescribers, generating consistent demand. Its multi-target approach allows patients to experience improved pain relief and nerve health with better adherence to treatment plans.

For franchise partners, Pregahike DM 75/30 Capsule is a high-demand neurological therapy product with excellent market acceptance. Its clinical efficacy, patient compliance, and prescriber confidence make it a profitable addition to neurology portfolios, helping expand business opportunities and attract loyal customers.

With its combination of pain relief and nerve repair, Pregahike DM 75/30 Capsule supports sustainable sales growth, making it an ideal choice for partners targeting neurology and chronic pain markets.

Read More

About the Product

Pregahike DM 75/30 Capsule contains Pregabalin 75mg + Methylcobalamin 1500mcg + Duloxetine 30mg, a triple-action therapy for effective management of neuropathic pain, nerve damage, and chronic pain conditions. Pregabalin reduces abnormal nerve signals, Methylcobalamin promotes nerve regeneration and repair, and Duloxetine enhances central pain modulation, ensuring complete nerve support.

This combination provides superior therapeutic benefits and is highly trusted by prescribers, generating consistent demand. Its multi-target approach allows patients to experience improved pain relief and nerve health with better adherence to treatment plans.

For franchise partners, Pregahike DM 75/30 Capsule is a high-demand neurological therapy product with excellent market acceptance. Its clinical efficacy, patient compliance, and prescriber confidence make it a profitable addition to neurology portfolios, helping expand business opportunities and attract loyal customers.

With its combination of pain relief and nerve repair, Pregahike DM 75/30 Capsule supports sustainable sales growth, making it an ideal choice for partners targeting neurology and chronic pain markets.

Common side effects may include dizziness, drowsiness, nausea, dry mouth, constipation, fatigue, and headache. Rarely, patients may experience blurred vision, mood changes, or allergic reactions. Severe or persistent side effects should be reported immediately to a healthcare professional.

Pregahike DM 75/30 Capsule is indicated for the treatment of neuropathic pain associated with diabetic neuropathy, post-herpetic neuralgia, peripheral neuropathy, and other chronic nerve-related disorders. It is also beneficial in patients experiencing sensory disturbances or nerve damage requiring both pain relief and nerve support.

Pregahike DM 75/30 Capsule should be taken under medical supervision. Do not discontinue the medication abruptly, as it may worsen symptoms or cause withdrawal effects. Caution is advised in patients with kidney impairment, liver disease, or a history of depression.

Store Pregahike DM 75/30 Capsule in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep out of reach of children and use only before the expiry date indicated on the packaging

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation